Norepinephrine: Difference between revisions

(Text replacement - "2 mg" to "2mg")
(Text replacement - "0 mg" to "0mg")
Line 33: Line 33:


==Adverse Reactions==
==Adverse Reactions==
*If extravasation occurs use phentolamine 0.1 to 0.2mg/kg (maximum dose 10 mg) subcutaneous in affected site<ref>ZUCKER G. et al. Treatment of shock and prevention of ischemic necrosis with levarterenol-phentolamine mixtures. Circulation. 1960 Nov;22:935-7.</ref><ref>PELNER L. et al. The problem of levarterenol (levophed) extravasation an experimental study.. Am J Med Sci. 1958 Dec;236(6):755-66</ref>
*If extravasation occurs use phentolamine 0.1 to 0.2mg/kg (maximum dose 10mg) subcutaneous in affected site<ref>ZUCKER G. et al. Treatment of shock and prevention of ischemic necrosis with levarterenol-phentolamine mixtures. Circulation. 1960 Nov;22:935-7.</ref><ref>PELNER L. et al. The problem of levarterenol (levophed) extravasation an experimental study.. Am J Med Sci. 1958 Dec;236(6):755-66</ref>
**Consult plastic/general surgery service to follow the patient and eval for need for intervention
**Consult plastic/general surgery service to follow the patient and eval for need for intervention


Revision as of 21:17, 22 July 2016

General

  • Type: Vasopressors
  • Dosage Forms:
  • Common Trade Names: Levophed

Adult Dosing

Dosing

Based on Glomerular Filtration Rate [GFR (ml/min)]

  • <10: 0.2mcg/kg/min
  • 10-40: 0.3mcg/kg/min
  • >40-50: 0.4mcg/kg/min
  • For CVVHD: dose at 0.4mcg/kg/min
  • For HD: dose 0.2mcg/kg/min

Rate of Titration

  • Q2-5 min

Pediatric Dosing

Special Populations

  • Pregnancy Rating:
  • Lactation:
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • If extravasation occurs use phentolamine 0.1 to 0.2mg/kg (maximum dose 10mg) subcutaneous in affected site[1][2]
    • Consult plastic/general surgery service to follow the patient and eval for need for intervention

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

Primary Receptor

  • α1 >> β1

Relative Effects

  • ↑↑↑SVR
  • ↑HR
  • ↑SV

Notes

More potent vasoconstrictor than dopamine and phenylephrine.

Indication

  • Septic shock (1st line)
  • Cardiogenic shock:
    • If marked hypotension (SBP <70)
    • If used with dobutamine

See Also

External Links

References

  1. ↑ ZUCKER G. et al. Treatment of shock and prevention of ischemic necrosis with levarterenol-phentolamine mixtures. Circulation. 1960 Nov;22:935-7.
  2. ↑ PELNER L. et al. The problem of levarterenol (levophed) extravasation an experimental study.. Am J Med Sci. 1958 Dec;236(6):755-66
Retrieved from "https://www.wikem.org/w/index.php?title=Norepinephrine&oldid=88506"